Australia’s Competition and Consumer Commission (ACCC) has approved Apotex and Strides Pharma Science’s agreement to merge their Australian businesses, deciding that the transaction “will not substantially lessen competition in any market”.
Australia’s Competition and Consumer Commission (ACCC) has approved Apotex and Strides Pharma Science’s agreement to merge their Australian businesses, deciding that the transaction “will not substantially lessen competition in any market”.
In its announcement, the ACCC said it had decided “not to oppose the merger” that was first announced earlier this...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
